Sunshine Biopharma

NASDAQ: SBFM
Nasdaq Stock Market
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#47550
Country Rank
#5738
Market Cap
2.93 M
Price
1.81
Change (%)
0.56%
Volume
58,477

Sunshine Biopharma's latest marketcap:

2.93 M

As of 07/20/2026, Sunshine Biopharma's market capitalization has reached $2.93 M. According to our data, Sunshine Biopharma is the 47550th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.93 M
Revenue (ttm) 35.49 M
Net Income (ttm) -6,039,450
Shares Out 1.62 M
EPS (ttm) -12.83
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/11/2026
Market Cap Chart
Data Updated: 07/20/2026

Sunshine Biopharma's yearly market capitalization.

Sunshine Biopharma has seen its market value grow from $2.54 M to $2.93 M since 2016, representing a total increase of 15.21% and an annual compound growth rate (CAGR) of 1.49%.
Date Market Cap($) Change (%) Global Rank
07/20/2026 $2.93 M -38.92% 47550
12/31/2025 $6.03 M 0.59% 39949
12/31/2024 $6 M -13.89% 40213
12/29/2023 $6.97 M -51.79% 38551
12/30/2022 $14.45 M -51.71% 34303
12/31/2021 $29.93 M 473.45% 30568
12/31/2020 $5.22 M 1941.74% 33876
12/31/2019 $255,600 -79.87% n/a
12/31/2018 $1.27 M -86.55% n/a
12/29/2017 $9.44 M 271.87% n/a

Company Profile

Sunshine Biopharma was founded in 2006 in United States. on the Nasdaq Stock Market. With 50 employees, it focuses on Healthcare and aims to drive innovation in Drug Manufacturers - Specialty & Generic.

Frequently Asked Questions

  • What is Sunshine Biopharma's (SBFM) current market cap?
    As of 07/20/2026, Sunshine Biopharma (including the parent company, if applicable) has an estimated market capitalization of $2.93 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Sunshine Biopharma global market capitalization ranking is approximately 47550 as of 07/20/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.